Korro Bio, Inc. (KRRO)
9.44
+0.53
(+5.95%)
USD |
NASDAQ |
Oct 20, 16:00
9.44
0.00 (0.00%)
After-Hours: 06:23
Korro Bio Net Income (Quarterly) : -18.92M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.92M |
| March 31, 2026 | -19.62M |
| December 31, 2025 | -50.04M |
| September 30, 2025 | -18.06M |
| June 30, 2025 | -25.77M |
| March 31, 2025 | -23.39M |
| December 31, 2024 | -21.20M |
| September 30, 2024 | -21.00M |
| June 30, 2024 | -21.83M |
| March 31, 2024 | -19.56M |
| December 31, 2023 | -39.22M |
| September 30, 2023 | -18.49M |
| June 30, 2023 | -17.65M |
| March 31, 2023 | -19.60M |
| Date | Value |
|---|---|
| December 31, 2022 | -17.36M |
| September 30, 2022 | -19.55M |
| June 30, 2022 | -21.28M |
| March 31, 2022 | -23.39M |
| December 31, 2021 | -21.50M |
| September 30, 2021 | -25.16M |
| June 30, 2021 | -17.66M |
| March 31, 2021 | -20.38M |
| December 31, 2020 | -10.23M |
| September 30, 2020 | -5.341M |
| June 30, 2020 | -6.025M |
| March 31, 2020 | -4.913M |
| December 31, 2019 | -5.493M |
| September 30, 2019 | -0.575M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 18.92M |
| EPS Diluted (Quarterly) | -1.074 |
| Enterprise Value | 66.00M |
| Earnings Yield | -106.0% |
| Normalized Earnings Yield | -78.82 |